P-glycoprotein (P-gp) and multidrug resistance related protein (MRP) overex
pression is often responsible of the development of multidrug resistance in
cancer therapy. These proteins ale also expressed in normal tissues, where
their physiological role is related to the extrusion of endogenous toxins
or to secretory function in liver and kidney. The LLC-PK1 cell line is deri
ved from normal pig proximal renal tubule and physiologically expresses low
levels of P-gp and MRP. A resistant cell line (LLC-PK1/ADR) has been estab
lished in our laboratory by chronic exposure to increasing doses of doxorub
icin. Cytofluorimetric analysis of P-gp and MRP expression performed by C21
9 and MRPm6 immunofluorescence detection showed that these cells overexpres
s P-gp, but nor MRP. The uptake of doxorubicin and rhodamine 123 has been q
uantified in LLC-PK1 and LLC-PK1/ADR cells and compared with data obtained
using other tumor cell lines commonly used as reference for studying P-gp o
r MRP overexpression. P388 sensitive cells and its resistant counterpart P3
88/ADR cells, which overexpress P-gp and PANC-1 cells, which express high l
evels of MRP were used. A lower fluorescence intensity was evident with bot
h doxorubicin and rhodamine 123 in LLC-PK1/ADR as well as in P388/ADR cells
, that overexpresses P-gp, in comparison with the parental fines. The uptak
e was increased by a pretreatment with verapamil. Verapamil was completely
ineffective on PANG-I cells, confirming a selective effect of this inhibito
r on P-gp. Propidium iodide staining, performed after doxorubicin treatment
, confirmed a higher cytotoxicity of the antineoplastic drug in the LLC-PK1
cells compared with the resistant counterpart.